In the United States, suicidality is a public health crisis, claiming over 49,000 lives annually and ranking among the top causes of death. For every suicide, approximately 25 others attempt it, impacting countless families and communities nationwide. Among young people aged 15-24, suicide is the second leading cause of death, highlighting the urgent need for targeted interventions in at-risk groups.

Adding to the complexity, suicidality is often linked to the side effects of other medications, particularly those prescribed for mental health conditions like depression and anxiety. For example, some antidepressants have been associated with increased suicidal thoughts, especially in younger patients during early treatment stages. This underscores the need for therapies specifically designed to address suicidality directly, rather than as a byproduct of broader mental health treatment.